Filip Borgions
Chief Tech/Sci/R&D Officer at ARGENX SE
Filip Borgions active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 2014-12-31 | - |
Career history of Filip Borgions
Former positions of Filip Borgions
| Companies | Position | Start | End |
|---|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Corporate Officer/Principal | - | - |
Training of Filip Borgions
| Katholieke Universiteit Leuven | Doctorate Degree |
Statistics
International
| Netherlands | 2 |
| Belgium | 2 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private companies | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Filip Borgions
- Experience
